In addition to influencing the immune infiltration of tumors, CCR5 can promote invasion and tumor cell migration by activating JAK/STAT3, MAPK/ERK, and PI3K/Akt signaling pathways (Huang et al., 2009). This evidence concerns the gene STAT3 and neoplasm.